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Little research has focused on the involvement of oxidative stress as it relates to
the pathophysiology of osteoarthritis (OA); while inflammation has been extensively
studied. The present study evaluates the ability to modulate the response of canine
chondrocytes to both inflammation and oxidative stress in an in-vitro model.
Chondrocytes were incubated and then stimulated to under-go oxidative stress by using
hydrogen peroxide or inflammation using interleukin-1 beta and tumor necrosis factor
alpha. For inhibition of oxidative stress an antioxidant, N-acetyl-cysteine, was used prior
to induction with hydrogen peroxide in a subset of chondrocytes. Measures of oxidative
stress were superoxide dismutase and reduced glutathione. Prostaglandin E2 was used as
a measurement of inflammation. Chondrocytes responded appropriately to both
oxidative stress and inflammation. The antioxidant N-acetyl-cysteine provided adequate
protection against oxidative stress. Oxidative stress and inflammation should be
considered to play a role in the pathophysiology of canine OA.
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CHAPTER I
INTRODUCTION
Background
Diarthrodial joints of dogs are highly specialized organs that function to allow
repetitive forces to be transmitted along the body in a pain free and frictionless
environment (1). The anatomy of a normal diarthrodial joint is composed of a joint
capsule, surrounding soft tissues, muscles, and tendons that contribute to the integrity and
movement of the joint. Muscle mass further limits joint movement so that it does not
exceed anatomical boundaries. Contained in the ligaments, tendons, and muscles are the
mechanoreceptors that aid in providing proprioceptive input and fine motor control to
prevent injury (2). Therefore, any disruption to the mechanoreceptors (i.e. trauma) will
decrease fine motor control and predispose the joint to injury (3). The joint capsule is
comprised of two layers, an outer fibrosis layer and an inner subsynovial layer both of
which are vascular and innervated. The synovial lining covers every structure in the joint
except the cartilage and menisci. Its function is to provide a low friction lining and
produce synovial fluid. Synoviocytes make up the synovial lining. Type A synoviocytes
are macrophage-like cells and function in phagocytosis. Type B synoviocytes are
fibroblast-like and function to produce hyaluronan and enzymes to nourish the
chondrocytes. Located throughout the synovium are cells that have immune function, and
therefore the synovium contributes to the inflammation that occurs in joint disease (4).
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Articular cartilage is a smooth compressible surface that transmits compressive
forces across subchondral bone. It functions as a load-bearing cushion within the joint.
Chondrocytes help to produce articular cartilage, specifically the extracellular matrix
(ECM); they are the only metabolically active component of articular cartilage and have
little capability to replicate. This is due to the lack of vascular, nervous, and lymphatic
supply. It receives it nutrition from the synovial fluid via diffusion. It is composed of
approximately 75-80% water, <5% chondrocytes, and an ECM.
The articular cartilage is composed of approximately 10% proteoglycan matrix,
and 10% type II collagen fibers that make up the ECM. The proteoglycan matrix has a
hyaluronic acid backbone. Aggrecan is a core protein with glycosaminoglycans attached
(GAGS). The aggrecan attach to hyaluronic acid to form an aggrecan aggregate, which
has a gel-like consistency with the ability to hold water. Aggrecan and water provide the
compressive stiffness to the tissues whereas collagen provides tensile strength. The
proteoglycan matrix is contained within a framework of mainly type II collagen. The
collagen forms interlocking loops that provide added support to withstand mechanical
forces (5, 6, 7).
Articular cartilage is divided into three zones (zones I to III), which is separated
from the calcified cartilage (zone IV) by the tidemark. In adult animals, zone I has the
highest cell density. In this zone the chondrocytes are small, flat, and oriented with the
long axis parallel to the surface. Zone II is characterized by larger and more rounded
cellular profiles while in zone III the chondrocytes are larger but arranged with their long
axis approximately perpendicular to the surface (8). The organization of the collagen
fibrils complements the cellular arrangement of articular cartilage. In the superficial zone
2

(zone I) the collagen fibrils are tangential to the articular surface. The middle zone (zone
II) has fibrils arranged in an intricate three-dimensional network with many of the fibrils
perpendicular to the surface and having branches that fan out. In the deep zone (zone III)
and the calcified zone the fibrils are perpendicular and form a more rigid mesh. This
organization allows each zone a specific function. In the superficial zone the layer forms
a pre-stressed, wear-resistant protective area that can withstand tension in the plane of the
articular surface. In contrast the fibrils in zones II and III are organized to provide
increased resilience to compressive loading. The concentration of proteoglycan increases
with increasing depth from the surface, which means that collagen fibrils are more
concentrated at the surface (9).

Osteoarthritis
Osteoarthritis (OA) is a chronic progressive disease affecting diarthrodial joints.
Estimates of 20% of middle aged and 90% of older aged dogs are affected by OA (10,
11). OA is a disease affecting the entire joint including: the articular cartilage, bone, and
synovium. However, the relationship between the pathology of each of these tissues is
poorly understood. Most attention has been focused on the articular cartilage in trying to
understand the pathophysiology of OA. Undoubtedly biomechanics play an important
role in disease initiation and progression in the articular cartilage, but biomechanical
changes occur in all joint tissues. OA is characterized clinically by joint pain, limitation
of movement, effusion, and variable degrees of inflammation. Biomechanically, a
reduction in proteoglycan concentration, alterations in size of aggregation, increased
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water content, collagen fibril disruption, and imbalance in the synthesis and degradation
of matrix macromolecules characterize OA (12).
The etiology of OA is not clear. It is proposed that the onset can be the result of
an abnormal stress on a normal joint (i.e. trauma, instability) that results from a single
event or repetitive microtrauma, or normal stress on an abnormal joint (i.e. genetic (13),
infection, inflammation) (1). Regardless of the cause, chondrocyte damage results in a
vicious cycle of extracellular matrix destruction; which is the hallmark of OA. This
degradation of the cartilage matrix results from an imbalance between chondrocyte
catabolic and anabolic events (14, 15, 16).

Role of inflammation in OA
Inflammation of the synovial membrane (synovitis) leads to the production and
release of inflammatory mediators from synoviocytes, which are mainly mononuclear
cells. A well coordinated system of cytokines and chemokines acts as attractants when
receptors have been activated. Chemokines are derived from chemotactic cytokines,
which are small heparin binding proteins that were originally defined by their
chemotactic activity. They are structurally related to cytokines, whose main function is to
regulate cell trafficking (17, 18). They are secreted in response to signals such as
proinflammatory cytokines where they have the important role of recruiting monocytes,
neutrophils, and lymphocytes (17). Currently in the human literature more than 50
chemokines and 20 chemokine receptors have been identified (19). Chemokines are
classified into four subfamilies based on the number and location of the cysteine residues
at the N-terminus. The fours subfamilies are C-X-C, C-C, and C (20, 21). The C-C and
4

C-X-C chemokines are further broken into 2 major subgroups. The C-X-C subgroup
contains interleukin-8 (IL-8), which will be discussed in detail later. The C-C chemokine
family comprises families of monocyte chemoattractant proteins (MCP-1, MCP-2, and
MCP-3) as well as others. Chemokines exert their roles by binding to the corresponding
G protein-linked cell surface receptors referred to as CXCR or CCR (18). In particular
MCP-1 (also known as CCL2) is a potent chemotactic factor for monocytes. MCP-1
recruits monocytes into areas of high inflammation, but the exact signaling pathways still
remain unclear. There is evidence to suggest the involvement of prostaglandin E2 (PGE2)
in the attraction of monocytes to the site of inflammation (22). It is produced by a variety
of cell types either at the time of or after the induction by oxidative stress, inflammation
(cytokines) growth factors (17), and tumor necrosis factor alpha (TNF-α), which have
been shown to upregulate MCP-1 expression in sensory neurons (23-25). More recently
MCP-1 expression has been found in chondrocytes (18). Seitz el al and Volin et al have
demonstrated both in-vivo and in-vitro that synoviocytes from OA patients revealed
production of IL-8, MCP-1, and macrophage inflammatory protein-1alpha (MIP-1α) (26,
27). Also, it was shown that chemokine receptors in human chondrocytes caused the
induction of metalloproteinases (discussed later), which were found to be enhanced in
OA chondrocytes (28). This particular study suggests a key role of the
chemokine/cytokine receptor system in OA. Furthermore, Yuan et al found that MCP-1
and its receptor CCR2 are expressed in both OA and normal chondrocytes but the
response to each was different with the stimulation of interleukin-1β (IL-1β) and TNF-α.
This suggests that the signaling pathways between normal and OA chondrocytes might be
different. They were also able to show that proteoglycan synthesis is inhibited by
5

chemokines (18). MCP-1 is one of the most studied chemokines and has been shown to
be a potential intervention point for the treatment of multiple diseases. The idea is that
once the signaling pathways of chemokines are more fully understood in OA then
treatment can be aimed at blocking the binding of MCP-1 to its receptor site thus
damping down the inflammatory response.
Inflammatory cells release a variety of inflammatory mediators such as
prostaglandins, leukotrienes, metalloproteinases (14), proteases, free radicals, interleukins
(17), tumor necrosis factor (17), and other cytokines. Of particular interest are the roles of
interleukin-6, interleukin-8, and IL-1β. IL-6 is a pleiotrophic cytokine that has a wide
range of roles from immunoregulation, mediation of acute-phase responses, and effects
on bone metabolism (29). IL-6 has been suspected in the inflammatory response observed
in patients with OA. This is further supported from studies showing that IL-6 knockout
mice were resistant to inflammatory arthritis and had reduced levels of serum TNF-α
(30). Elevated levels of IL-6 in both serum and synovial fluid of patients with OA seem
to correlate with clinical and laboratory indices of disease activity (31). In multiple
studies IL-6 is elevated in OA, which is associated with inflammation as well as cartilage
and bone destruction (32, 33). Blocking IL-6 with its interactions with the IL-6 receptor
(IL-6R) by using IL-6R antagonists reduces cartilage/bone destruction and invasion of
cartilage by synovium in animal models and human patients (30, 34).
IL-8 is also produced in arthritic joints by activated synovial cells, and along with
IL-6, is considered to be a potent catabolic factor in OA (29). IL-8 induces a massive
accumulation of neutrophils, which produce neutrophil elastase. This leads to cartilage
destruction. Furthermore, IL-8 injections have been shown to induce the expression of
6

IL-1β in the joint cavity (35). Several papers have reported that IL-1β is one of the most
active catabolic cytokines in OA and plays a pivotal role in the pathogenesis of OA (3639). As a result of Il-1β release, metalloproteinases such as collagenase-3 (MMP-13) and
gelatinase A (MMP-2) are increased as well as production of nitric oxide (NO) which
leads to collagen and chondrocyte destruction (15). It was discovered that the free
radical, inducible nitric oxide (iNOS), expression in chondrocytes can be induced by a
single stimulation of Il-1β or TNF-α while in other types of tissues multiple cytokines are
required. The development of OA proinflammatory mediators such as IL-1β and TNF-α
not only play a major role at inducing inflammation but also oxidative stress leading to
the production of prostaglandins.
Prostaglandins are lipid mediators that have been shown to be locally increased in
patients with OA (40). The origination of prostaglandins comes from the insult causing
the release of arachidonic acid from the phospholipids of the chondrocytes. Once
arachidonic acid is released, it causes the secretion cyclooxygenase and lipoxygenase.
Lipoxygenase is responsible for causing the release of leukotrienes, while
cyclooxygenase is responsible for the release of different prostaglandins such as PGE2,
which has catabolic effects on chondrocytes. These catabolic effects result in increased
release of other inflammatory mediators such as metalloproteases (MMP’s) and IL-1β
(41). PGE2 has also been shown to be involved in multiple conditions such as apoptosis,
angiogenesis, structural changes, osteoclastic bone resorption (40), and symptoms of OA
(42). It has been noted that cyclooxygenase production (especially COX-2) is upregulated in both OA and rheumatoid arthritis, thus leading to increased levels of PGE2
(41). Berenbaum et al discovered that TNF-α would induce cyclooxygenase expression
7

(especially COX-2) without concurrent release of IL-1β in rabbit chondrocytes; however,
both TNF-α and IL-1β act synergistically to cause the release of PGE2 (43).

Role of oxidative stress in OA
It is proposed that free radical are involved in the pathophysiology of OA. One
theory is that oxidative stress and inflammation work synergistically together to cause
extracellular matrix destruction. It was shown that MMP’s and reactive oxygen species
(ROS) are the two main mediators of matrix component degradation (41). However, more
is known about inflammation while very little is known about the exact mechanisms
oxidative stress plays on canine chondrocytes.
Oxidative stress can be defined as the imbalance of the oxidant-antioxidant ratio
where the oxidant outweighs the antioxidant (44). This occurs by the free radicals
indiscriminately reacting with molecular oxygen forming ROS (45). Excess ROS such as
nitric oxide synthase (NOS), myeloperoxidase (MPO), nitrite, hydroxyl radical,
superoxide anions, and hydrogen peroxide attack fatty acids, phospholipids, DNA, and
RNA causing cell damage (41, 45). ROS causes damage to DNA by altering nucleic acids
by base modification, double base lesions, and strand breaks (44, 45). Yudoh et al found
that oxidative stress can induce chondrocyte telomere instability leading to chondrocyte
senescence, and a decreased cellular replicative lifespan (46). Molecular oxygen is
capable of accepting electrons becoming reduced to superoxide anion which functions as
a strong oxidizing agent; but is not stable in aqueous solution and therefore can dismutate
to hydrogen peroxide. Hydrogen peroxide is a weaker oxidizing agent than superoxide
anion, and acts as an inducer of oxidative stress by interacting with metals such as
8

copper, Cu (I), and iron, Fe (I) which gives rise to reactive and toxic hydroxyl radicals
through the Fenton reaction creating multiple free radicals and thus causing cellular
destruction and/or apoptosis (45, 47-49). Multiple studies have proven that inflammation
is a key secondary mediator involved with OA, however; only recently has the roles of
oxidative stress been addressed in the development and progression of OA. It has been
revealed that inflammatory mediators such as IL-1β can induce the production of ROS,
along with macrophages, polymorphonuclear leukocytes (50), and chondrocytes (51) but
the exact role ROS plays remains unclear. In vitro studies further showed that activation
with either IL-1β or TNF-α increase iNOS expression in chondrocytes while in other
types of tissues multiple cytokines are required (52).
As previously mentioned articular cartilage is an avascular tissue where its
nutrients come from synovial fluid and the oxygen tension is only about 1-7% (52, 53).
Several studies found that in vivo oxygen tension in cartilage is lower than 8%, therefore;
chondrocytes have to be able to survive in a low oxygen environment (54, 55). Grimshaw
et al found that oxygen tension below 1% will inhibit glucose uptake, lactate production
and RNA synthesis, which indicate that some oxygen is needed for chondrocyte
metabolic activity (56).
The ability of oxygen to modulate chondrocyte activity is still not fully
understood, making it difficult to extrapolate data from other cell types regarding its
oxidative response. For example, in vitro studies have evaluated the response of oxidative
stress in the liver (57) which is a vascular organ receiving 70-80% of cardiac output and
having an oxygen tension that is approximately 20-30%. An additional problem is that
the self-healing ability of cartilage is severely limited due to its avascularity, lack of
9

innervation and lymphatic circulation, as well as low cellularity (58). In certain
circumstances, oxygen may be transformed into ROS, which plays a role in cellular
functions such as cell proliferation, activation, and cell death. Low levels of ROS can act
as different secondary messengers in the expression of a wide variety of gene products;
however, high levels can lead to cell destruction and death (59, 60).

Management of OA: Pharmacologic and Non-Pharmacologic Treatment
Approaches
A major barrier in managing OA is the fact that it is not a single disease, but
rather a disease with different pathophysiological mechanisms that results in damage to
type II collagen (14). Multiple therapies have been developed to combat the
pathophysiology of OA as well as to relieve pain. Currently a multimodal approach to
help decrease inflammation and reduce pain with the use of NSAIDS, intra-articular
steroids, oral opioids, omega-3 fatty acids (61-63), polysulfated glycosaminoglycans
(64), dietary restriction (65), and chondroprotecants is utilized. Because OA is a chronic
and progressive disease new therapies are sought to help decrease the severity of clinical
signs. Research has not yet yielded information that identifies any therapeutic modalities
to combat oxidative stress in OA such as the use of antioxidants. In human in vitro
studies oxidative stress and inflammation are reported to work together in the induction
of extracellular matrix destruction. Previous studies demonstrated that MMPs and ROS
are the two main key participants in matrix component degradation (15).
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CHAPTER II
MODULATION OF INFLAMMATION AND OXIDATIVE STRESS IN CANINE
CHONDROCYTES
Objectives
The objectives of this study are to further investigate how oxidative stress
influences the pathophysiology of canine osteoarthritis and to evaluate if the same
inflammatory mediators will cause not only an inflammatory response but also an
oxidative stress response. Additionally, an insight into the ability of an antioxidant (Nacetyl-cysteine) to counter-act the influence of oxidative stress was sought. Our
hypotheses are: (1) canine chondrocytes will respond to the oxidative stressor hydrogen
peroxide (H2O2), (2) canine chondrocytes will exhibit an oxidative stress and
inflammatory response to the inflammatory cocktail of interleukin-1 beta (IL-1β) and
tumor necrosis factor-alpha (TNF-α), and (3) the oxidative stress induction can be
inhibited with an antioxidant.
Materials and Methods
Cell Culture
Articular cartilage was harvested from canine stife joints and aseptically diced
into <5 mm pieces. The cartilage was digested with type II collagenase (110 U/ml)a for
12-18 hours at 37ºC in 5% CO2. Chondrocytes were filtered through a wire mesh screen
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to remove debris and rinsed four times with Hank’s Balanced Salt Solutionb. Cells were
counted and assessed for viability using the Trypan-blue exclusion method, and
propagated in monolayer culture until confluency in canine chondrocyte mediac.

Experimental Design
Chondrocytes (5 x 105) were seeded onto 6-well plates and maintained at 37°C
with 5% CO2 for 24 hrs. To assess induction of oxidative stress cells were incubated for
24 hours with: (1) canine chondrocyte media, (2) H2O2 at 100, 200, or 300 µM, or (3) a
cytokine cocktail of IL-1β (10 ng/ml) and TNF-α (1 ng/ml). To determine if this
induction could be inhibited, selected wells were pre-incubated for 24 hours with Nacetyl-cysteine (NAC) at 10 mM before exposure to H2O2. The effect of cytokines on
chondrocyte inflammation was tested by incubating cells with control media alone or
with IL-1β (10 ng/ml) and TNF-α (1 ng/ml) for 24 hours. Supernatants and lysates were
frozen at -80ºC for further analysis of PGE2 or measurement of SOD enzyme activity and
GSH levels.

PGE2 High Sensitivity Immunoassay
A commercially available PGE2 immunoassayd kit was used to quantify secreted
PGE2 levels in the cellular supernatant, according to the manufacturer’s instructions. A
PGE2 standard was run in parallel to the supernatant samples in parallel with triplicate
samples. Optical density was measured immediately following incubation using the
SpectraMAX 340 microplate readere at 450 nm with wavelength correction set at 540 nm.
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SOD Determination Assay
A commercial SOD kitf was used to quantify secreted SOD activity (% inhibition
rate) in the cell lysate, according to the manufacturer’s instructions. An SOD activity
standard was run in parallel to the lysate samples using 20µL of each standard and
samples were plated onto a 96 well plateg in triplicates. The plates were then incubated at
37°C for 20 minutes. Optical density was measured immediately using the SpectraMAX
340 microplate readere at 450 nm.

GSH Assay
The GSH assay was modified from Prieto-Sagredo (1), et al using 0.1 M Sodium
Phosphate-0.005 M EDTA Buffer: pH = 8, 0.1% w/v o-phthalaldehyde (OPT), and 200
µg/ml glutathione stock were all prepared according to authors description. GSH
standards were run in parallel to the lysate samples. Optical density was measured
immediately using the SpectraMAX Gemini XS microplate readere set at excitation 350
nm and emission 420 nm.

Phenotype Analysis by Immunohistochemistry
Chondrocytes were plated on microscope slides and fixed with 10% v/v
paraformaldehdye and immunostained as previously described (2,3). Briefly, slides were
incubated with goat anti-type I collagen, anti-type II collagen, or anti-aggrecan
antibodiesh. The slides were next washed in phosphate buffered salinei three times and
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incubated with FITC labeled anti-goat antibodies. Immunostaining was visualized using a
Nikon Eclipse epifluorescent microscope TE200.

Statistical Analysis
Data is presented as the mean ± SD. Pair-wise multiple comparisons were carried
out using one-way ANOVA, Tukey post-hoc using SigmaStat statistical software
(Windows Version 3.11) where p<0.05 was considered statistically significant. The
Sigma Stat program verified that our data is compatible with the assumptions of
Normality- Gaussian distribution and homogenous variance.

Results
Characterization of canine chondrocyte phenotype
The majority of cultured canine chondrocytes immunostained for type II collagen.
A few cells were shown to immunostain for both type II collagen and type I collagen
while an insignificant number immunostained with type I collagen alone (Figure 1). All
cells immunostained for aggrecan. This observation indicates that most of the
chondrocytes studied maintained features of their original phenotype of articular cartilage
in the joint.

The effect of oxidative stress on SOD expression in canine chondrocytes
The chondrocytes exposed to 100, 200, and 300 µM of H2O2 revealed depletion of
SOD activity compared to the chondrocytes cultured in control media alone (p<0.001 for
all 3 concentrations, Figure 2). Pre-treatment with 10mM NAC followed by incubation
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with 100, 200, or 300 µM H2O2 significantly increased SOD activity when compared to
the activated chondrocytes alone (p<0.001, p=0.001, p=0.003, respectively, Figure 2).
There was no significant difference in the SOD activity between the control media and
the cells pre-treated with NAC followed by activated with any concentration of H2O2
(Figure 2).

The effect of oxidative stress on GSH levels in canine chondrocytes
Activation with 100, 200, or 300 µM of H2O2 decreased GSH levels; however,
this was not significant when compared to the chondrocytes cultured in control media
alone (Figure 3). Pre-treatment with 10mM NAC followed by activation with 100, 200,
or 300 µM H2O2 significantly increased GSH levels when compared to the activated
chondrocytes (p<0.001 for all three H2O2 concentrations, Figure 3) and control media
(p<0.001 for all three H2O2 concentrations respectively, Figure 3).

The effect of cytokines on SOD activity in canine chondrocytes
Chondrocytes cultured with the control media alone showed higher levels of SOD
activity compared to cytokine-activated chondrocytes (Figure 4). The chondrocytes
activated with a cocktail of 10 ng/ml IL-1β and 1 ng/ml TNF-α revealed significantly
decreased levels of SOD activity at 24 and 48 hour activation compared to the
chondrocytes cultured in control media alone (p<0.001, and p=0.026, respectively, Figure
4). The response was time-dependent with a significantly greater decrease noted 48 hours
post activation (Figure 4).
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Figure 1
Immunostaining of canine chondrocytes
Immunostaining of canine chondrocytes showing few cells staining for collagen type I
(red), while the majority of cells stain for collagen type II (green)
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Figure 2
Effect of H2O2 on Chondrocyte SOD Activity
SOD activity in response to H2O2 concentrations (100, 200, 300 µM) and NAC (10 mM)
in canine chondrocytes lysates (mean ± SD). H2O2 completely depleted SOD activity.
*Mean SOD values were statistically significant when incubated with H2O2 (p<0.001 for
100, 200 and 300 µM H2O2) compared to control (C). **Treatment with NAC
significantly increased SOD values (p<0.001 for 100, 200 µM, p=0.003 for 300 µM
H2O2) compared to cells activated with H2O2 alone
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Figure 3
Effect of H2O2 on Chondrocyte GSH Levels
Intracellular GSH levels following exposure to H2O2 concentrations (100, 200, 300 µM)
and NAC (10 mM) (mean ± SD). *Mean GSH levels decreased when activated with all
concentrations of H2O2 compared to controls (C); however this response was not
significant. **Treatment with NAC significantly increased GSH values (p<0.001 for 100,
200, and 300 µM H2O2) compared to activated cells and compared to control (p<0.001
for 100, 200, and 300 µM H2O2)
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Figure 4
Effect of Cytokine Induced Inflammation on Chondrocyte SOD Activity
SOD activity in canine chondrocyte cellular lysate (mean ± SD) following 24 and 48 hr
activation. Mean SOD activity levels are shown as percent of cytokine activated control.
*Mean values were statistically significant (p<=0.001 for 24 hr, p=0.026 for 48 hr)
compared to control values (C)

The effect of cytokine on PGE2 production in canine chondrocytes
Cytokines IL-1β and TNF-α are well known pro-inflammatory mediators and
induced the production of PGE2. Chondrocytes activated with a cocktail of 10 ng/ml IL1β and 1 ng/ml TNF-α for 24 and 48 hours exhibited significantly increased levels of
PGE2 when compared to the chondrocytes cultured in control media alone (p<0.001 and
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p=0.010 respectively, Figure 5). No statistically significant difference was noted between
the chondrocytes at the 24 and 48-hour activation periods, but PGE2 levels were slightly
decreased at 48 hours (Figure 5). The PGE2 production was expressed as a percentage of
control due to the varying production levels amongst different sets. However, as a whole
the trends were noted to be similar (Figures 6 and 7).

Discussion
The principal finding of the present study is that oxidative stress can be inducted
with either hydrogen peroxide or cytokines in an in vitro canine chondrocyte culture
model. Most of the chondrocyte cultures used in the present study immunostained
intensely for type II collagen indicating that they maintained features of the cartilage
phenotype (Figure 1). We then showed that H2O2 or cytokines induce an oxidative stress
response as demonstrated by a decrease in intracellular SOD (Figures 2 and 4). Similar to
earlier findings our results also show that chondrocytes respond to cytokine activation,
reflected by a marked increase in PGE2 production (Figure 5). These findings are
consistent with other published data in humans where oxidative stress has been
implicated in the progression and development of OA (4-7).
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Figure 5
Effect of Cytokine Induced Inflammation on Chondrocyte PGE2 Levels
PGE2 levels (ng/ml) in canine chondrocyte supernatant (mean ± SD) following 24 and 48
hr cytokine activation expressed as percent of cytokine activated controls. Mean PGE2
levels released into the cellular supernatant are shown as percent of activated control.
*Mean values were statistically significant (p<0.001 for 24 hr,
p<0.01 for 48 hr) compared to control values (C)
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Figure 6
Effect of Cytokine Induced Inflammation on Chondrocyte PGE2 Levels: 24 hr. activation
Representative PGE2 levels in 3 separate runs to show differences in concentration
between canine chondrocyte cell lines following 24 hr. cytokine activation
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Figure 7
Effect of Cytokine Induced Inflammation on Chondrocyte PGE2 Levels: 48 hr. activation
Representative PGE2 levels in 3 separate runs to show differences in concentration
between canine chondrocyte cell lines following 48 hr. cytokine activation

The observations in the present study identified mediators known to be involved
in the development of OA. Proinflammatory mediators such as IL-1β and TNF-α play a
major role at inducing both inflammation and oxidative stress leading to the production
of prostaglandins, particularly PGE2. Production of this lipid mediator has been shown to
be increased in the joints of patients with OA (8). PGE2 has catabolic effects on
chondrocytes, which result in increased release of other inflammatory mediators such as
MMPs and IL-1β (9). PGE2 has also been shown to be involved in multiple conditions
such as apoptosis, angiogensis, structural changes, and osteoclastic bone resorption (8),
which are displayed in OA (10). Cyclooxygenase-2, the key enzyme that controls PGE2
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production is upregulated by TNF-α (11). IL-1β and TNF-α induced inflammation in our
chondrocyte cultures in agreement with other studies in showing that PGE2 levels
significantly increase with activation (Figure 5) (8, 12, 13).
The present study showed that SOD levels can be induced using three different
concentrations of H2O2 (Figure 2). Depleted stores of SOD secondary to increased levels
of ROS may help explain this observation. Overtime SOD could possibility be exhausted,
thereby removing one of the first lines of defense against ROS, which may lead to
cellular damage and apoptosis. The role of ROS and SOD has been implicated in clinical
studies such as those of Scott et al who reported diminished SOD levels during end stage
OA in human cartilage (14).
To prevent toxicity/cell death by ROS, chondrocytes are thought to have a wellcoordinated antioxidant enzyme system consisting of SOD, catalase, and GPX. SOD
transforms superoxide anion into H2O2 and oxygen. SOD plays an important role in
managing ROS but is also very limited because H2O2 can still cause oxidative stress if
other detoxification enzymes (i.e. GPX, catalase) are ineffective or depleted (15). We
chose to use SOD as a biomarker of oxidative stress because it is the most abundant
antioxidant available both intracellularly and extracellularly. During inflammation and/or
oxidative stress, oxidative defense genes (i.e. SOD) are reported to be down-regulated in
multiple tissues including astrocytes and chondrocytes (6, 16, 17). SOD has been
discovered in three isoforms in humans. SOD1 (Cu/Zn-SOD) is found in the cytoplasm,
nucleus, and intermembrane space of mitochondria. In the mouse model SOD1 mutations
are associated with increased apoptosis and oxidative protein damage, and play a central
role in cell survival (18). Overproduction of the inflammatory marker, TNF-α, has been
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associated with increased oxidative stress consistent with decreases in SOD1 expression
(19). TNF-α suppresses SOD1 production may explain the generation of superoxide
anion. This also suggests its involvement in inflammatory and oxidative stress conditions
as was shown in this study (18). SOD2 is found in the mitochondria and has been shown
to provide a pivotal role against ROS generated by hyperoxia. Inflammatory cytokines
such as IL-1β and TNF-α are well known activators of SOD2, which also contains sites
that bind to NF-κB (20). ROS may induce transcription factors binding activity and can
then act as secondary messengers of cytokines (21). SOD3 (EC-SOD) is found in the
extracellular space; both isoforms (SOD1 and SOD3) use copper and zinc as cofactors.
SOD3 has a strong affinity for proteoglycans in the ECM. Its main function is to protect
cells and the ECM against the effects of superoxide anion (18). SOD2 has been shown to
be down-regulated in OA while SOD3 is decreased in human OA and a mouse model of
OA (16, 22, 23). Recently Scott et al found that all three SOD family members (SOD1,
SOD2, and SOD3) were down regulated in diseased cartilage. It was shown in Hartley
guinea pigs that down-regulation of SOD2 precedes the development of OA lesions
raising the suspicion that SOD2 expression may be associated with the earliest stages of
OA (14). Our results are consistent with these reports showing decreased levels of SOD
in states of increased oxidative stress and inflammation (Figures 2 and 4).
Although not statistically significant, our results indicate that GSH levels tend to
decrease upon exposure to H2O2 (Figure 3). It may be possible that SOD levels are
exhausted prior to glutathione being activated. However, little is known about GSH in
response to oxidants in chondrocytes. It would be informative if future research could
focus on both isoforms of glutathione (oxidized and reduced), and evaluate their
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expression in relation to acute and chronic oxidative stress in canine chondrocytes.
Glutathione is one of the most abundant cellular antioxidants (24), it serves as a substrate
for enzymes such as glutathione peroxidase which neutralizes H2O2 and other peroxides
during oxidative stress (25). Glutathione has been shown to be an effective ONOOscavenger (26). A portion of the glutathione system is glutathione reductase, and its two
forms: GSH, and GSSG, which play a primary role in detoxifying H2O2 and other
peroxides to water and oxygen (27). During oxidative stress, glutathione reductase
regenerates GSH from GSSG using NADPH. This activity was reported to prevent GSSG
from leaving the cell and creating a GSH depletion environment, which can favor
apoptosis (25, 28).
Under known oxidative stressors and glutathione depletion, cell death was
significantly increased. In conditions where GSH was abundant, the chondrocytes were
protected from the same oxidative stressors (25). This protection could occur as increased
levels of GSH serve as a substrate for the glutathione peroxidase pathway thus
eliminating H2O2 and other toxic peroxides (29). Studies have shown that apoptotic cell
death is found in chondrocytes in articular cartilage of both OA and rheumatoid arthritis
patients (25). It was proposed that chondrocytes may have been deprived of GSH, and are
thus more prone to oxidative stress. These cells may be unable to detoxify or scavenge
different ROS (28). Reduced levels of GSH can have damping effects on the production
of cartilage extracellular matrix components. Because of GSH depletion, dysregulated
production of ROS could reduce the production of proteoglycan and hyaluronic acid
(29,30).
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The present study also showed that NAC inhibited oxidative stress in our stressed
chondrocyte cultures (Figures 2 and 3). This is reminiscent of Ueno’s study where
treatment with NAC not only restored GSH, but also increased the glutathione reserves
(31). The exact mechanism for this observation is unknown, but may be due to rapid
depletion and inability to rapidly regenerate SOD stores. NAC may help keep the SOD
expression from becoming completely depleted. In contrast, GSH expression is not
readily exhausted, and therefore the NAC not only maintains GSH levels to prevent
apoptosis, but also gives a protective effect by increasing GSH stores. Another possible
explanation is that NAC could serve as a substrate to help replenish or maintain GSH
levels. Currently, only a few antioxidants have been explored for the management of
oxidative stress in response to chondrocyte damage. NAC has been shown to protect
temporo-mandibular chondrocytes from oxidative stress by fully restoring viability and
function of chondrocytes and increasing glutathione reserves in the presence of H2O2
(31.)
A major limitation to our study is that using an in vitro model does not
recapitulate every condition in vivo. However, this canine chondrocyte culture model
provided a useful tool to show that oxidative stress can be induced with H2O2 or the
combination of IL-1β and TNF-α.

Footnotes
a

Gibco Invitrogen, Carlsbad, CA, USA

b

ATCC; Manassas, VA, USA

c

Cell Applications, Inc; San Diego, CA, USA
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d

R&D Systems, Minneapolis, MN, USA

e

Molecular Devices, Sunnyvale, CA, USA

f

Sigma-Aldrich, St. Louis, MO, USA

g

Corning Costar, Corning NY, USA

h

Southern Biotechnology Associates; Birmingham, AL USA

i

PBS, Gibco Invitrogen, Carlsbad, CA, USA
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CHAPTER III
CONCLUSION

The principal finding of the present study is that oxidative stress can be inducted
with either hydrogen peroxide or cytokines in an in vitro canine chondrocyte culture
model. Most of the chondrocyte cultures used in the present study immunostained
intensely for type II collagen indicating that they maintained features of the cartilage
phenotype. We then showed that H2O2 or cytokines induce an oxidative stress response as
demonstrated by a decrease in intracellular SOD. Similar to earlier findings our results
also show that chondrocytes respond to cytokine activation, reflected by a marked
increase in PGE2 production. It was also shown that NAC inhibited oxidative stress in our
stressed chondrocyte cultures. This in vitro model facilitated the study of cellular events
involved with oxidative stress and inflammation. This model may be used for additional
research to evaluate agents that inhibit oxidative stress and/or inflammation with the goal
being to improve clinical management of canine OA.
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